Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|July 5, 2005
Gene therapy for lysosomal storage diseasesT M Daly, M S Sands
Pediatric Research|June 1, 2000
Abnormal immune function in vivo in a murine model of lysosomal storage diseaseT M Daly, R G Lorenz, M S Sands
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage diseaseT M Daly, C Vogler, B Levy, et al.
Gene Therapy|September 26, 2001
Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transferT M Daly, K K Ohlemiller, M S Roberts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VIIW A Frisella, L H O'Connor, C A Vogler, et al.
Molecular and Cellular Biology|November 1, 1987
TFIIIA binds to different domains of 5S RNA and the Xenopus borealis 5S RNA geneM S Sands, D F Bogenhagen
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VIIM S Sands, E H Birkenmeier
Pageof 7